Persistent major alopecia following adjuvant docetaxel for breast cancer: incidence, characteristics, and prevention with scalp cooling

Association Between Use of a Scalp Cooling Device and Alopecia After Chemotherapy for Breast Cancer

(2017) Hope S. Rugo et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Effect of a Scalp Cooling Device on Alopecia in Women Undergoing Chemotherapy for Breast Cancer

(2017) Julie Nangia et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Permanent alopecia in patients with breast cancer after taxane chemotherapy and adjuvant hormonal therapy: Clinicopathologic findings in a cohort of 10 patients

(2017) Athina Fonia et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Aromatase inhibitors induce 'male pattern hair loss' in women?

(2013) A. Rossi et al.   ANNALS OF ONCOLOGY

Permanent scalp alopecia related to breast cancer chemotherapy by sequential fluorouracil/epirubicin/cyclophosphamide (FEC) and docetaxel: a prospective study of 20 patients

(2012) N. Kluger et al.   ANNALS OF ONCOLOGY

Breast cancer scalp metastasis as first metastatic site after scalp cooling: Two cases of occurrence after 7- and 9-year follow-up

(2011) Julie Lemieux et al.   BREAST CANCER RESEARCH AND TREATMENT